MFS Meridian European Value W1 GBP
Europe Including UKPricing frequency
Daily
Dealing cut off time
16:45
Type
SICAV
Yield
–
NAV
£26.22
Income frequency
-
Ongoing charge
1.17%
Latest actual NAV date
13-11-2026
ISIN
LU1320600379
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 31/10/2026 | % of assets |
|---|---|
| ASML Holding NV | 5.88 |
| AstraZeneca PLC | 3.07 |
| ING Groep NV | 2.73 |
| SAP SE | 2.69 |
| Novartis AG Registered Shares | 2.60 |
| Schneider Electric SE | 2.60 |
| TotalEnergies SE | 2.44 |
| AIB Group PLC | 2.33 |
| Iberdrola SA | 2.26 |
| Unilever PLC | 2.14 |
Investment objective
The Fund’s objective is capital appreciation, measured in euros. The Fund invests primarily (at least 70%) in European equity securities. Some of the countries in Europe, primarily those in Eastern Europe, are currently considered emerging market economies. The Fund generally focuses its investments in companies it believes to be undervalued compared to their intrinsic value (value companies). The Fund may invest in companies of any size. The Fund may invest a relatively large percentage of its assets in a small number of companies. The Fund may invest a relatively large percentage of the Fund’s assets in a small number of countries and/or a particular geographic region.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.